BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
8 results:

  • 1. Development and validation of a preoperative CT-based risk scoring system for predicting recurrence-free survival in patients undergoing curative surgery for gastric cancer.
    Zhu Z; Gong H; Gu J; Dai Y; Yang C; Mao M; Song A; Feng F
    Eur J Radiol; 2024 Feb; 171():111303. PubMed ID: 38215532
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]    [Full Text] [Related]  

  • 3. Alpha-fetoprotein for gastric cancer staging: An Essential or Redundant Tumor Marker?
    Tsai CY; Liu KH; Chiu CT; Hsueh SW; Hung CY; Hsu JT; Tsang NM; Hung YS; Chou WC
    Anticancer Res; 2021 May; 41(5):2711-2718. PubMed ID: 33952502
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Discordance of Clinical and Pathologic staging in Locally Advanced gastric Adenocarcinoma.
    Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
    J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
    Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
    BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Value of staging information provided by linear-array endoscopic ultrasound for therapeutic response and prognosis prediction in gastric lymphoma.
    Tingyu H; Jianqiang L; Zuguang X; Xiujiang Y; Ke C
    Dig Endosc; 2021 Sep; 33(6):929-938. PubMed ID: 33124105
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Unmet Needs of the Diagnosis, staging, and Treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.